LOADING
Comparing Eli Lilly and Company (LLY) and Visa Inc (V) across the Health Care and Financials sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | LLY | V |
|---|---|---|
| Price | $1,007.78 | $322.56 |
| Change Today | -0.78% | +0.70% |
| Market Cap | $905.9B | $615.9B |
| P/E Ratio | 36.1 | 28.3 |
| Forward P/E | 26.3 | 24.5 |
| PEG Ratio | 1.28 | 1.67 |
| EPS | $28.11 | $11.46 |
| Revenue Growth (YoY) | 55.5% | 17.1% |
| Profit Margin | 35.0% | 51.7% |
| Return on Equity | 107.5% | 60.4% |
| Dividend Yield | 0.63% | 0.82% |
| Beta | 0.48 | 0.78 |
| 52-Week High | $1,132.06 | $372.56 |
| 52-Week Low | $620.46 | $293.28 |
| Volume | 57K | 124K |
Eli Lilly and Company is the larger company by market capitalization. Visa Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Visa Inc offers a higher dividend yield for income investors. Visa Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.